Macquarie Medical School researchers have developed a technique for a gene therapy that could help treat the world's leading cause of irreversible blindness. The findings are published in the journal Molecular Therapy.
Jun 27, 2023
0
36
Glaucoma is the leading cause of irreversible blindness worldwide. Primary open-angle glaucoma (POAG) is the most common form, and yet the cause of this disease is poorly understood. Findings from previous genome-wide association ...
Jun 13, 2023
0
6
Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.
Mar 10, 2023
0
40
U.S. federal health officials have issued recall notices for two more brands of eye drops.
Mar 8, 2023
0
2
An international team of researchers led by Lithuanian scientists provide additional evidence that intracranial pressure plays an important role in normal-tension glaucoma, which accounts for up to 50 percent of all glaucoma ...
Feb 13, 2023
0
68
Glaucoma is a common ocular disease in which the optic nerve malfunctions due to the increased intraocular pressure (IOP) caused by drainage canal blocking in the eye. This condition narrows the peripheral vision and can ...
Feb 1, 2023
0
1986
Glaucoma is one of the world's leading causes of blindness, according to the Centers for Disease Control and Prevention. January is Glaucoma Awareness Month. Half of people with glaucoma don't even know they have it. If you're ...
Jan 27, 2023
0
7
A comprehensive eye exam could be the key to determining if you have glaucoma, a silent thief of sight.
Jan 4, 2023
0
15
Glaucoma is the leading cause of irreversible blindness due to optic nerve damage and the death of retinal ganglion cells (RGCs). Presently, reducing intraocular pressure is the sole evidence-based therapy for glaucoma patients, ...
Dec 20, 2022
0
45
Deep learning plays an increasingly crucial role in biomedical research, due to its exceptional data processing capacity. However, single-feature data is far from enough to present the full picture of an issue.
Dec 15, 2022
0
5
